(Q44454385)

English

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting

scientific article published in June 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

author name string

Atul Aggarwal

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

David J Schneider

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Edward F Terrien

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Christopher M Terrien

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Burton E Sobel

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Harold L Dauerman

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1346-1349

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Widespread coronary inflammation in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Eptifibatide blocks the increase in C-reactive protein concentration after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reop

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Morphological predictors of restenosis after coronary stenting in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900327-8

7 January 2021

Identifiers

10.1016/S0002-9149(03)00327-8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44454385&oldid=2024696874"